Venatorx Pharmaceuticals has filed a notice of an exempt offering of securities to raise $16,350,000.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, Venatorx Pharmaceuticals is raising $16,350,000.00 in new funding. Sources indicate that as part of senior management President, Christopher Burns played a key role in securing…